I think that some traders were expecting a rise in SP prior to the release of the latest set of trial results as occured last time, and seem to be bailing out, given the relatively low volume. Usually, there is no movement prior to results but last time, Quest happened to be accumulating and the SP increased by 20-30%. Nothing to be concerned about at this stage.
.
- Forums
- ASX - By Stock
- VLA
- Ann: VLA to Present CAVATAK Clinical Data at Upcoming Conferences-VLA.AX
Ann: VLA to Present CAVATAK Clinical Data at Upcoming Conferences-VLA.AX, page-32
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online